ESC 365 - Prognosis of patients in end-stage heart failure with atrial fibrillation treated with ablation - Insights from Castle HTX

EHRA Premium Access

Prognosis of patients in end-stage heart failure with atrial fibrillation treated with ablation - Insights from Castle HTX

Session: Late-Breaking Science today and tomorrow

Topic: Catheter Ablation of Arrhythmias

Speaker: Professor C. Sohns (Bad Oeynhausen, DE)

Event: EHRA 2024

Congress Presentation

Add to my library

About the speaker

Professor Christian Sohns

Heart and Diabetes Center NRW, Bad Oeynhausen (Germany)

10 presentations

1 follower

4 more presentations in this session

Future LBS - Ground-breaking electroporation-based intervention for paroxysmal atrial fibrillation treatment: Rational and Design of the BEAT PAROX-AF randomized clinical trial

Speaker: Professor P. Jais (Bordeaux, FR)

Future LBS - CAtheter-Based Ablation of atrial fibrillation compared to conventional treatment in patients with Heart Failure with Preserved Ejection Fraction

Speaker: Doctor A. Parwani (Berlin, DE)

Future LBS - Initial Clinical Experience with the Volt PFA System: Acute Results of the VOLT CE Mark Feasibility Substudy

Speaker: Professor P. Sanders (Adelaide, AU)

Future LBS - Safety, effectiveness and PVI durability of contact force-sensing dual energy focal ablation technology integrated with 3D mapping to treat paroxysmal atrial fibrillation: SmartfIRE study results

Speaker: Doctor T. De Potter (Aalst, BE)

Access the full session

Late-Breaking Science today and tomorrow

Speakers: Professor C. Sohns, Professor P. Jais, Doctor A. Parwani, Professor P. Sanders, Doctor T. De Potter

About the event

EHRA 2024

7 April - 9 April 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources